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ABSTRACT 
In the present century due to the busy and sedentary life people open the gate to welcome 
numerous diseases. Sthoulya is one among the major diseases that falls under the category of 
Santarpanottha vyadhi. The term overweight and obesity refers to body weight that is greater 
than what is considered healthy for a certain height. Sthoulya is mainly caused by Kapha, Vata 
Doshas and Meda Dhatu. Udvartana has better results in the management of Sthoulya, as it does 
Kapha-Vatahara, Medo vilayana. So, the present has been conducted to compare and evaluate 
the effect of Haridradi gana Churna and Triphala Churna Udvartana in Sthoulya. The study has 
been conducted in two groups with 20 patients each. One with Haridradi gana Churna and other 
group with Triphala Churna which are Kapha-Medahara & Kapha-Pramehahara respectively 
because of Laghu, Ruksha & Ushna properties. The present study concludes saying Haridradi 
gana Churna showed better results than Triphala Churna. 
KEYWORDS: Sthoulya, Santarpanottha Vyadhi, Obesity, Udvartana, Vata, Kapha, Meda. 
INTRODUCTION 
Sthoulya is one among the major diseases that 
falls under the category of Santarpanottha Vyadhi 
(Nutritional disorder).[1] The term overweight and 
obesity refers to body weight that is greater than 
what is considered healthy for a certain height and 
hence overweight can be commonly said as pre 
obesity. According to W.H.O overall about 13% of the 
world’s adult population (11% men and 15% 
women) were obese in 2016. The world wide 
prevalence of obesity nearly tripled between 1975 
and 2016.[2] Obesity is a condition in which the levels 
of Lipoproteins, Cholesterol and Triglyceride are 
raised in plasma. Obesity is a major risk factor in the 
development of chronic non-communicable diseases 
like cardiovascular disease, high blood pressure, 
stroke, type-2 diabetes, osteoarthritis, liver cirrhosis, 
exertion dyspnoea, varicose veins, PCOS etc. [3] There 
is no much treatment available for obesity other than 
physical exercise, supervised low-calorie diet, 
appetite suppressant drugs and surgery. [4] 
In the texts of Ayurveda, an elaborate 
description has been given about Sthoulya. Sthoulya 
comes under 20 Kaphaja Nanatmaja Vyadhi[5]. 
Acharyas considered Atisthula as one among the 
Astonindita Purusha. [6] Sthoulya is mainly caused by 
Kapha, Vata Doshas and Meda Dhatu. [7] Sthoulya 
interferes the daily activities as it causes Athyadikya 
Sweda Pradurbhava (excessive sweating), Swasa-
kruchata on Alpa shrama (exertion dyspnoea), 
Jadyata (stiffness), Alpabala (lack of strength), 
Sharira dourgandha (bad body odour) etc. [8] 
Nidana Parivarjana (avoiding the causative 
factors), Karshana, Guru atarpana and Shodhana 
(purification) are the principles of treatment in 
Sthoulya. [9] The utility of Udvartana has found better 
results in the management of Sthoulya. It is a 
Rukshana type of treatment where medicated 
powder is rubbed over the body in opposite direction 
of hair root with tolerable pressure. It does Kapha-
Vatahara (subsides Kapha and Vata), Medo vilayana 
(Liquefies fat), Sthirikarana of anga (brings stability 
in the body) etc. [10] In this present study Udvartana is 
done with Haridradi gana Churna (Group A) which 
acts as Kapha Meda hara [11] by its property of Laghu 
Ruksha guna and Ushna veerya and Triphala Churna 
(Group B) is used for other group which acts as 
Tridosha hara.[12] Both Haridradi gana and Triphala 
Churna played a good role in treating Sthoulya. The 
present study was conducted with 40 patients, which 
were randomly distributed into two groups. The 
subjective and objective parameters were assessed 
before, after treatment and after follow up. 
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MATERIALS AND METHODS 
Patients suffering from Sthoulya were 
selected randomly from IPD & OPD of   D.G.M. 
Ayurvedic Medical College Hospital and Research 
Centre, Gadag based on diagnostic criteria. The trial 
drugs are collected from local areas and market after 
being properly identified. Haridradi gana Churna and 
Triphala Churna were prepared in the D.G.M. 
Ayurvedic Medical College Pharmacy. 
 Composition of Trial Drug 
Table.1 Haridradi Gana Churna 
Drugs Latin name Part used Quantity  
Haridra  Curcuma longa Linn. Kanda 1 part 
Yastimadhu Glycyrrhiza glabra Linn. Moola 1 part 
Daruharidra  Berberis aristata DC. Kanda 1 part 
Prishnaparni  Uraria picta Desv. Moola 1 part 
Kutaja  Holarrhena antidysenterica Wall. Twak  1 part 
Table.2 Triphala Gana Churna 
    Drugs    Latin name Part used Quantity 
    Haritaki    Terminalia chebula Retz Phala 1 part 
    Bibhitaki    Terminalia bellerica Roxb Phala 1 part 
    Amalaki    Embilica officinalis Gaertn Phala 1 part 
Inclusion criteria 
 Patient with Prathyatma Lakshana (cardinal 
symptoms) of Sthoulya. 
 Patient fit for Udvartana. 
 BMI > 25Kg/m2 
 Patients of either sex aged between 18 to 60 
years. 
Exclusion criteria: 
 Patient unfit for Udvartana. 
 Other systemic diseases like cardio vascular 
disease, PCOD, uncontrolled diabetes etc which 
will interfere the treatment. 
 Patients aged below 18 years and above 60 
years. 
Study design: It was a simple prospective 
comparative clinical study and total 40 patients were 
taken in 2 groups equally i.e. Group A and Group B. A 
comparative clinical study was done by treating the 
patient with Haridradi gana Churna Udvartana and 
Triphala Churna Udvartana respectively. 
Posology: 
Group A: 20 patients were subjected to Udvartana 
for 45 minutes with Haridradi gana Churna    for 10 
days. 
Group B: 20 patients were subjected to Udvartana 
for 45 minutes with Triphala Churna for 10 days. 
The procedure of Udvartana was carried out as 
explained in the Ayurvedic texts. 
Duration of treatment :   10 days 
Follow up   :  15 days 
Total duration of study:  25days 
Patients were assessed clinically on 0, 10th and 25th 
day. 
Assessment criteria: Assessment of the condition 
was done based on a detail Proforma, adopting 
standard methods of scoring of subjective and 
objective parameter and was analyzed statistically. 
Subjective parameters with grading: 
Ati kshudha (excessive hunger) 
1. Feels hunger at next Annakala-0 
2. Feels hunger for once in between Annakala-1 
3. Feels hunger twice in between Annakala-2 
4. Feels hunger more than twice in between 
annakala-3 
 Atipipasa: (excessive thirst) 
1. 2.5 lit to 3.0 lit water per day -0 
2. 3.0 lit to 4.0 lit water per day-1 
3. 4.0 lit to 5.0 lit water per day-2 
4. More than 5.0 lit water per day-3 
Nidradhikya: (excessive sleep) 
1. 6-8 hours sleep/day-0 
2. 8-9 hours sleep/day-1 
3. 9-10 hours sleep/day-2 
4. More than 10 hours sleep/day-3 
Alasya/Utsaha hani: (lassitude) 
1. Absent-0 
2. Doing work satisfactory but initiation late in 
time-1 
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3. Doing work unsatisfactory with initiation late in 
time with lot of mental stress-2 
4. Does not have initiation & do not want to work 
even after motivation-3 
Swasakruchata: (difficulty in breathing) 
1. Absent-0 
2. On accustomed work-1 
3. Less than accustomed work-2 
4. At rest-3 
Objective parameter 
1. Body Mass Index  = weight (kg)  
    Height (m2) 
2. Waist circumference= Circumference around 
the waist (inc) 
3. Waist hip ratio= Waist circumference 
Hip circumference 
4. Skin fold thickness= Sum of skin fold thickness 
(mm) 
(Triceps skin fold + Biceps skin fold + Sub scapular 
skin fold + Suprailiac skin fold) 
Overall assessment: Overall assessment of result 
was made by considering the collective effect of 
objective and subjective parameters of each group. 
The assessment is as follows:  
 Well responded 76-100% relief in assessment 
criteria. 
 Moderately responded 51-75% relief in 
assessment criteria. 
 Responded 25-50% relief in assessment criteria. 
 Unchanged <25% relief in assessment criteria. 
Statistical method: Assessment was done by 
considering the base line data of subjective and 
objective parameters to pre and post medication and 
was analyzed statistically with the help of SPSS 
software by using “t” test.  
Investigations: (Before treatment only) 
 RBS  
 Lipid profile. 
RESULTS 
Table 3: Statistical Analysis of Group A (Bt and AF) 
 Mean MD Reduction SD SE t p Re- 
marks BT AF 
Atikshudha 0.75 0.20 0.55 73.33% 0.686 0.153 3.584 0.002 S 
Atipipasa 0.40 0.15 0.25 62.5% 0.44 0.099 2.517 0.021 S 
Nidradhikya 1.00 0.35 0.65 65% 0.745 0.17 3.901 0.001 HS 
Alasya 1.25 0.2 1.05 84% 0.394 0.088 11.92 0.0005 HS 
Swasakruchata 1.05 0.000 1.05 100% 0.605 0.135 7.764 0.0005 HS 
BMI 30.95 30.17 0.78 2.5% 0.3738 0.0836 9.278 0.0005 HS 
Waist circumference 42.53 41.325 1.2085 2.84% 0.87 0.195 6.209 0.0005 HS 
Waist Hip Ratio  0.94 0.937 0.007 0.74% 0.026 0.006 1.196 >0.05 NS 
Skin fold thickness 108.70 100.70 8.00 7.36% 4.304 0.962 8.312 0.0005 HS 
Table 4: Statistical Analysis of Group B (BT and AF) 
 Mean MD Reduction SD SE t p Remarks 
BT AF 
Atikshudha 0.40 0.25 0.15 37.5% 0.37 0.82 1.831 >0.05 NS 
Atipipasa 0.30 0.15 0.15 50% 0.37 0.082 1.831 >0.05 NS 
Nidradhikya 1.05 0.35 0.7 66.66% 0.73 0.164 4.273 0.0005 HS 
Alasya 1.35 0.35 1.00 74.07% 0.459 0.103 9.747 0.0005 HS 
Swasakruchata 1.20 0.05 1.15 95.8% 0.489 0.109 10.510 0.0005 HS 
BMI 31.60 30.9 0.70 2.22% 0.612 0.137 5.12 0.0005 HS 
Waist circumference 40.92 39.89 1.03 2.52% 0.84 0.188 5.493 0.0005 HS 
Waist Hip ratio 0.94 0.93 0.12 12.24% 0.02 0.0046 2.529 0.020 S 
Skin fold thickness 103.95 94.8 9.15 8.8% 4.69 1.0495 8.718 0.0005 HS 
BT-Before treatment, AF- After follow-up, MD- mean deviation, SD- Standard deviation, SE- Standard error 
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DISCUSSION 
In the present study maximum incidence of 
Sthoulya was found in females than in male and most 
of them belong to age group between 26-35 years 
and belong to mixed diet. Caesarean delivery, 
Vishamashana (taking food irregularly or without 
following a particular time and proper quantity) and 
Hereditary factors are the main causes found in 
obese females. 
Discussion on drug 
Sthoulya is associated with Kapha 
predominant, Vata Dosha and Meda dathu. Haridradi 
gana acts as Meda-Kaphahara in nature. Haridra, 
Daruharidra, Kutaja have Laghu (light) Ruksha (dry) 
guna; Haridra, Daruharidra, Prishnaparni have Ushna 
veerya (hot potency); Yastimadhu have the karma of 
Kapha nissaraka. On the whole all these drugs have 
opposite qualities of Kapha and Meda acts as Kapha 
Medahara. So, this Gana was selected for Udvartana. 
Apart from these properties Haridra has Varnya guna 
(improves complexion) hence during the study we 
have also noted that the patients were happy to 
express their results like change in skin complexion 
and skin texture especially with Haridradi gana 
Churna Udvartana. 
Triphala acts as Kaphaghna and Prameha nashaka 
(anti-diabetic). In Prameha (diabetes) Kapha-Meda is 
mainly involved and so as in Sthoulya. Haritaki, 
Vibhitaki and Amalaki have Ruksha and TriDoshahara 
guna (reduces three Doshas), Haritaki and Vibhitaki 
has Laghu guna and Ushna veerya. Hence this group 
of drugs is selected for Udvartana. 
Discussion on Udvartana procedure 
As Sthoulya is one of the Santarpanajanya 
vyadhi it is best dealt with Apatarpana Chikitsa. 
Udvartana is a procedure of rubbing dry powder over 
the body with tolerant pressure in the opposite 
direction of the hair roots. Udvartana does Kapha, 
Vatahara and Meda vilayana. There by it may reduce 
Gurutva (Heaviness), Alasya (Lazy), Swasa krichrata, 
Dourgandhya. 
Probable mode of action of Udvartana 
The medicated powder is rubbed over body 
in the opposite direction of hair root. Rubbing may 
help in the absorption of effusions, relief of blood 
stasis and carries away the morbid products in the 
system. The pressure helps the contents of the blood 
vessels move towards the heart, if applied strongly 
and quickly, it has a stimulating effect. It increases 
nutrition in tissues, removes fatigue, carries away the 
increased products of combustion. The skin as well as 
the structures which lie beneath it is affected by 
massage. The stored amount of blood may be brought 
in the systemic circulation instead of them remaining 
dormant in the stored system. 
Udvartana has Kapha-Meda vilayana 
property. To enhance the Medovilayana property, 
Katu-Tikta rasa (pungent-bitter); Ushnavirya; Laghu-
Ruksha-Tikshna guna dravyas are present. Twakastha 
agni gets stimulated, this leads to absorption and 
digestion of the drug and further does Pravilayana of 
Medha Dhatu (liquefaction of subcutaneous fat) 
below skin may occur. In Sthoulya there is increase in 
vikruta Meda Dhatu which increases Kleda. Due to 
kleda, srotas (channels) get obstructed and abaddha 
Meda Dhatu (loose fat) is formed. This may lead to 
Dhatu agni mandya (decreased molecular level fire of 
MedaDhatu). Due to Ushna, Tikshna, Laghu property 
of the Dravya and procedure, it acts as Medahara. Due 
to Ruksha guna of Dravya and Ruksha Udvartana, 
kleda gets absorbed (Shoshane Ruksha|| Hemadri) 
Thus Abaddhatva of Meda and Kapha might have 
reduced. 
Discussion on Result of clinical study 
 Atikshudha: In the present Clinical study 
observation is made that, Group A having 
statistically high significance in reducing the 
symptom of Atikshudha where as Group B is not 
having statistical significance. The treatment 
response for Atikshudha statistical value shows 
that there is difference between Group A and 
Group B. In reduction % Group A is better than 
Group B. The reduction % is increased in Group A 
and remains same in Group B after follow up. 
 Atipipasa: In the present Clinical study 
observation is made that, Group A and Group B 
both are statistically non significant in reducing 
the symptom of Atipipasa. The treatment response 
for Atipipasa statistical value shows that there is 
difference between Group A and Group B. In 
reduction % Group A is better than Group B. The 
results remain same even after follow up in both 
groups.   
 Nidradhikya: In the present Clinical study 
observation is made that, Group A and Group B 
both are statistically highly significant in reducing 
the symptom of Nidradhikya. The treatment 
response for Nidradhikya statistical value is equal 
in both groups. In reduction % Group A is better 
than Group B after treatment, but after follow up 
Group B is better than Group A. 
 Alasya/Utsaha hani: In the present Clinical study 
observation is made that, Group A and Group B 
both are statistically highly significant in reducing 
the symptom of Alasya/Utsaha hani. The 
treatment response for Alasya/Utsaha hani 
Int. J. Ayur. Pharma Research, 2019;7(2):40-45 
     IJAPR | February 2019 | Vol 7 | Issue 2  44 
statistical value is equal in both groups. In 
reduction % Group A is better than Group B. After 
follow up the reduction % is increased in Group A 
and remains same in Group B. 
 Swasakruchrata: In the present Clinical study 
observation is made that, Group A and Group B 
both are statistically highly significant in reducing 
the symptom of Swasakruchrata. The treatment 
response for Swasakruchrata statistical value is 
equal in both groups. In reduction % Group B is 
better than Group A, but after follow up Group A is 
better than Group B. 
 BMI: In the present Clinical study observation is 
made that, Group A and Group B both are 
statistically highly significant in reducing the BMI. 
The treatment response for BMI statistical value is 
equal in both groups. In reduction % Group A is 
better than Group B. The result remains same even 
after follow up. 
 Waist circumference: In the present Clinical 
study observation is made that, Group A and 
Group B both are statistically highly significant in 
reducing the Waist circumference. The treatment 
response for Waist Circumference statistical value 
is equal in both groups. In reduction % Group A is 
better than Group B. Even though the reduction % 
is reduced in Group A after follow up but still it is 
better than Group B. 
 Waist-Hip ratio: In the present Clinical study 
observation is made that, Group B having 
statistically significance in reducing the Waist-hip 
ratio where as Group A is not having statistical 
significance. The treatment response for Waist-hip 
ratio statistical value shows that there is 
difference between Group A and Group B. In 
reduction % Group B is better than Group A. After 
follow up the reduction % remain same in Group B 
but slightly reduced in Group A. 
 Skin fold thickness: In the present Clinical study 
observation is made that, Group A and Group B 
both are statistically highly significant in reducing 
the Skin fold thickness. The treatment response 
for Skin fold thickness statistical value is equal in 
both groups. In reduction % Group B is better than 
Group A. After follow up reduction % is same in 
Group B and raised in Group A, but still the Group 
B is better than Group A. 
Discussion on overall assessment of treatment  
After observing the above subjective and 
objective parameter, the effect of the therapy has 
been classified as good responded, moderate 
responded, mild responded and not responded. From 
the clinical data out of 40 patients 95% patients 
showed response and 5% patients was not 
responded to treatment (i.e., 1 patient each from 
Group A & Group B). 57.5% showed mild response 
(23 patients i.e., 8 patients from Group A & 15 
patients from Group B), 35% showed moderate 
response (14 patients i.e., 10 patients from Group A & 
4 patients from Group B) and 2.5% showed good 
response (1 patient from Group A).   
CONCLUSION 
In the present study both groups are having 
similar effect on reducing the symptoms statistically. 
Among the subjective and objective parameters like 
Atikshudha, Nidradhikya, Alasya, BMI and Waist 
circumference Group A showed better reduction % 
than Group B. In parameters like Atipipasa, 
Swasakruchata, Waist-hip ratio and skin fold 
thickness Group B showed better reduction % than 
Group A. The symptoms of Atikshudha, 
Swasakruchata and Skin fold thickness have 
increased reduction % in follow up period of Group A 
(Haridradi gana Churna). By comparing the results of 
both the groups Group A is better than Group B.  
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